Senologia ApS: Financial statements 2023
CVR: 41258640
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Senologia ApS (CVR 41258640) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 12,589,266 and a net result of DKK 2,222,313 compared with DKK 290,972 the year before. That is an increase of 6.9% compared with the year before. Equity in the 2023 report amounted to DKK 6,896,143. The solvency ratio was 78.3%. The company had 10 employees in the financial year.
- Gross Profit
- DKK 12,589,266
- Profit/Loss
- DKK 2,222,313
- Equity
- DKK 6,896,143
- Total Assets
- DKK 8,803,205
- Employees
- 10
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 12.6M | 2.2M | 6.9M | 10 |
| 2022 | - | 11.8M | 291K | 3.5M | 11 |
| 2021 | - | 7.6M | 2.7M | 3.2M | 3 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Senologia ApS has published its annual report for 2022. Gross profit came to DKK 11,779,221, and the net result was DKK 290,972.
As of June 13, 2023, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of Senologia ApS.
About Senologia ApS
Senologia ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2020. The company is registered under the industry Alment praktiserende lægers aktiviteter. The management consists of Rógvi Winthereig Rasmussen. The company is owned by ROGVI AB. The company has 6 employees (2026). In 2025, the company reported a gross profit of DKK 8,506,795 and a net result of DKK 298,253 compared with DKK 1,286,028 the year before. Equity in the 2025 report amounted to DKK 3,480,424.
